Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Mitsubishi Tanabe Kicks Off Multinational PIII of Edaravone Oral Suspension for ALS
November 26, 2019
- Takeda’s Dengue Vaccine Demonstrates Consistent Efficacy in PIII
November 26, 2019
- Sunovion Resubmits Sublingual Parkinson’s Drug in US
November 26, 2019
- AbbVie Enters Japan Oncology Market with Venclexta Rollout
November 25, 2019
- Lung Cancer Drug Portrazza Now Available in Japan: Nippon Kayaku
November 25, 2019
- Takeda R&D Chief Touts Pipeline Revolution, 70% of Research Now in Non-Small Molecules
November 22, 2019
- Parkinson’s Med Haruropi Tape to Hit Shelves on Nov. 29: Kyowa Kirin/Hisamitsu
November 22, 2019
- As BMS Closes Celgene Buy, Japan Integration Gets Underway; 132 Otezla Staffers to Move to Amgen JV
November 22, 2019
- Astellas Links Up with US Health Tech Welldoc in Digital Therapeutics
November 22, 2019
- Evenity Debut, Copycat Entries Set to Jolt Power Map of Japan Osteoporosis Market
November 21, 2019
- Kyowa Kirin Launches Japan PIII for Acoalan in Preeclampsia
November 21, 2019
- Japan’s 1st HIF-PH Inhibitor Hits Market, Kyorin Pushes Back Lasvic Launch amid Desalex Resupply
November 20, 2019
- 70% of Japanese Still Think HIV Is “Deadly Disease”: Gilead Survey
November 20, 2019
- Sumitomo Dainippon to Solely Promote Novartis Diabetes Meds from January
November 20, 2019
- Mitsubishi Chemical to Fully Own Mitsubishi Tanabe to Solidify Healthcare Platform
November 19, 2019
- Fujifilm Kicks Off US PI Study for Topotecan Liposome Drug
November 19, 2019
- Takeda Eyes 12 NME Approvals over Next 5 Years
November 19, 2019
- Shionogi Wins US Approval for Antibiotic Fetroja
November 18, 2019
- Stemirac’s 44 Million Yen Sales Within Expectations, Says Nipro President
November 15, 2019
- Big 3 Generic Firms Enjoy 7.8% Growth, AG Makers Triumph: Jiho Tally
November 15, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…